Heartflow's quarterly loss widened over the year-ago period, the healthcare company disclosed in its paperwork for a U.S.

Heartflow is once again looking for a path to go public, with a filing for a Nasdaq IPO. | The former Fierce Medtech Fierce ...

Heartflow, an artificial intelligence-based medical device software developer, filed for an initial public offering in the United States on Thursday. The U.S. IPO market is witnessing a renewed vigor ...

Heartflow has filed for an initial public offering. The company recorded sales of $125.8 million and a net loss of $96.4 million last year, according to a filing with the Securities and Exchange ...

Heartflow Inc. continued the steady rhythm of med-tech companies filing to go public, with an S-1 submitted to the U.S. SEC ...

“HeartFlow’s AI-driven technology offers a compelling value proposition for both clinicians and patients and is enhancing the care paradigm for patients with coronary artery disease.

Category I CPT code for Fractional Flow Reserve derived from Computed Tomography will provide broader access to HeartFlow’s AI-powered technology, a standard of care for evaluating and treating ...

HeartFlow Inc. has raised a fresh funding round that puts the company’s valuation over $1.5 billion. and Baillie Gifford led the a $240 million Series E, with participation from existing ...

HeartFlow uses medical imaging to create more complete models of patients' cardiovascular systems; it's a non-invasive technology aimed at improving treatment and reducing unnecessary procedures ...

Now HeartFlow has developed a new technology called Planner which takes things a step further by allowing doctors to virtually model surgery in real-time.

In a bold bid to electrify Wall Street and revolutionize how heart disease is diagnosed, Heartflow, a medical technology ...

HeartFlow, Inc. today announced the closing of its Series E financing, securing $240 million. The company will use the proceeds from this financing to ...